Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 35 Advanced Solid Tumors 20 Carcinoma, Non-Small-Cell Lung 14 Myelodysplastic Syndromes 13 Breast Neoplasms 13 Advanced Solid Tumor 13 Recurrence 10 Ovarian Neoplasms 8 Neoplasms 8 Multiple Myeloma 8 Leukemia, Myelomonocytic, Chronic 8 Triple Negative Breast Neoplasms 7 Solid Tumor 6 Myeloproliferative Disorders 6 Small Cell Lung Carcinoma 5 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Lung Neoplasms 5 Carcinoma, Hepatocellular 5 Advanced Solid Tumour 5 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Fallopian Tube Neoplasms 4 Colorectal Neoplasms 4 Advanced Malignant Solid Tumor 4 Advanced Lung Cancer 4 Squamous Cell Carcinoma of Head and Neck 3

Interventions

atezolizumab 2 Control Groups 2 Blood Specimen Collection 2 Bevacizumab 2 repotrectinib 1 pembrolizumab 1 durvalumab 1 User-Centered Design 1 Standard of Care 1 Patient Navigation 1 Neuropsychological Tests 1 Neoadjuvant Therapy 1 Liver Transplantation 1 Injections 1 Immunotherapy 1 Electroporation 1 Catheter Ablation 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × Injections × 1 year × Clear all

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡